Live Breaking News & Updates on Allogene Therapeutics Daily|Page 4
Stay updated with breaking news from Allogene therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Average Recommendation of "Moderate Buy" from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics (NASDAQ:ALLO) Rating Reiterated by HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics (NASDAQ:ALLO) vs. Tenaya Therapeutics (NASDAQ:TNYA) Financial Analysis themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its target price decreased by JPMorgan Chase & Co. from $9.00 to $8.00 in a research note published on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. A number of other equities research analysts also recently weighed in on the […] ....
MBB Public Markets I LLC Reduces Stock Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.